Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%

Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier. According to the filing with the Securities and Exchange Commission, Baker Bros. holds 3.4% of the company’s common stock, down from 5.1% held previously. Overall, in several deals, Baker Bros. Raised its position MEI Pharma, from 345,317 shares owned at the end of the third quarter of 2013.

MEI Pharma

MEI Pharma a development-stage oncology company; develops drugs for the treatment of cancer. Recently MEI Pharma Inc (NASDAQ:MEIP) priced an underwritten public offering of 4.38 million shares of its common stock at an offering price of $8.00 per share. The total gross proceeds of $35 million from the offering will be used to further the progress of clinical development programs for its drug candidates, Pracinostat, ME-344 and PWT143.

Recently, Deerfield Management, run by James E. Flynn, increased its holdings in MEI Pharma Inc (NASDAQ:MEIP) from 822,199 shares to 1.4 million shares representing 6.38% of the company. Jacob Gottlieb and his fund Visium Asset Management disclosed in October that the fund has amassed 931,767 shares of MEI Pharma representing 5.4% of the company. Nine Chapters Capital Management, led by Chao Ku, initiated a position in the stock in the third quarter of 2013 and holds 55,100 shares worth $1.54 million.

Julian and Felix Baker’s Baker Bros. Advisors focuses mainly on biotechnology companies. Recently the fund had raised its stake in Seattle Genetics, Inc. (NASDAQ:SGEN) from 20.5 million shares to 20.9 million shares, the stake included 112,500 shares under options, held directly by Felix Baker representing a 17.1% stake in the company’s common stock. Earlier in the first week of December, the fund had bought an additional 1.0 million shares of Seattle Genetics.

Julian and Felix Baker earlier had reduced its stake in Incyte Corporation (NASDAQ:INCY) from 30.20 million to 19.53 million shares and holds 11.8% in the company. The fund’s majority of the holding constitute of Pharmacyclics Inc (NASDAQ:PCYC) which constitute 9.01 million shares worth $1.25 billion.

Disclosure: none

Recommended Reading:

Empire Capital Management Adds Veeva Systems Inc (VEEV) to Its Equity Portfolio

SAC Capital Ups Stake in Crocs, Inc. (CROX)

Warren Buffett Reveals Holding 30.5% of USG Corporation (USG)’s Stock

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!